ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Letters to The Editors: Donald Coffey Finds Sensationalism Hurts

June 6, 1997

Afinitor Significantly Reduced Tumor Size In TSC-Related Renal Angiomyolipomas

January 25, 2013

“I’m Not Bummed Out By This” – Broder

December 22, 1994

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

NCI-Approved CTEP Trials For the Month of October

October 26, 2012